Maternal serum ferritin and fetal growth.
OBJECTIVE
To determine the relationship between maternal serum ferritin and concentrations and specific types of fetal growth restriction (FGR).


METHODS
Serum ferritin concentrations were measured at approximately 25 and 36 weeks' gestation in 480 multiparas with singleton fetuses who participated in a study of risk factors for repeated FGR. Asymmetric FGR was defined by low birth weight for gestational age criteria and a ponderal index less than 2.32, and symmetric FGR was defined by the same birth weight for gestational age criteria and a ponderal index of at least 2.32.


RESULTS
Among 480 infants, 370 were appropriate for gestational age (AGA), 58 had asymmetric FGR, and 52 had symmetric FGR. Higher ferritin concentrations were associated with black race, maternal age 25 years or older, and smoking. Mothers of asymmetric-FGR infants had higher mean ferritin levels than mothers of AGA infants at 25 weeks' (38.0 versus 20.2 microg/L, P < .01) and 36 weeks' gestation (21.0 versus 13.3 microg/L, P < .01), whereas mothers of symmetric-FGR infants had significantly lower ferritin levels at 36 weeks (8.3 microg/L). For mothers with serum ferritin levels of at least 26 microg/L (highest quartile at 25 weeks), the adjusted odds ratio (OR) for asymmetric-FGR infants was 3.4, 95% confidence interval (CI) 1.6, 7.2. There was a similar association between the highest quartile of serum ferritin at 36 weeks (at least 20 microg/L) and asymmetric FGR (adjusted OR 2.7, 95% CI 1.3, 5.8). Women with serum ferritin levels less than 3 microg/L (lowest quartile at 36 weeks) had an adjusted OR for symmetric-FGR infants of 2.2, 95% CI 1.01, 4.6.


CONCLUSIONS
High maternal serum ferritin levels are associated with asymmetric FGR, whereas low serum ferritin levels are associated with symmetric FGR.
Hou
J
J
Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 35294, USA. jhou@civmail.circ.uab.edu
Cliver
S P
SP
Tamura
T
T
Johnston
K E
KE
Goldenberg
R
R
D005314:Embryonic and Fetal Development; D005260:Female; D005293:Ferritins / Q000097:blood*; D005317:Fetal Growth Retardation / Q000453:epidemiology*; D006400:Hematocrit; D006801:Humans; D016015:Logistic Models; D011247:Pregnancy / Q000097:blood*; D012307:Risk Factors
D005293:Ferritins